Vascular sealant market forecast points to 8% annual growth by 2030

The global vascular sealant market is projected to grow from $1.71 billion in 2025 to $2.51 billion by 2030, driven by more surgery, rising cardiovascular disease and broader use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Vascular sealants help stop bleeding during surgery, support tissue repair and reduce hemorrhage risk. - Faster growth in the market points to rising demand for products that improve surgical efficiency and patient recovery. - The market’s expansion is tied to broader healthcare trends, including more cardiovascular procedures and more minimally invasive surgery.

What happened: - The Business Research Company projected the vascular sealant market will rise from $1.71 billion in 2025 to $1.85 billion in 2026. - The report forecast the market will reach $2.51 billion by 2030. - The company said the market will grow at a 7.8% CAGR from 2025 to 2026 and an 8.0% CAGR through 2030. - The report was released in London on July 8, 2026. - The company offered a free sample of the report and the full vascular sealant market report.

The details: - Growth over the next several years is expected to come from greater adoption of minimally invasive surgeries. - The report pointed to higher investment in surgical innovation, more outpatient surgical centers and a stronger focus on patient safety and quicker recovery times. - Key trends include wider use of advanced hemostatic agents and demand for fast-acting, durable sealants. - The report also highlighted development of bioresorbable and biocompatible materials. - Multi-use sealants across multiple surgical specialties are another trend named in the report. - Vascular sealants are specialized medical adhesives made from synthetic or biological materials. - The products form a barrier when they contact blood or tissue. - The report said these products are used to reduce complications in surgeries, especially in cardiovascular care. - The report covered Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Between the lines: - Rising cardiovascular disease is the clearest demand driver in the report. - The report linked that demand to aging populations and risk factors such as obesity, diabetes, hypertension, poor diet, sedentary lifestyles and smoking. - The Scottish Health Survey 2024 found 16% of adults in Scotland reported some form of cardiovascular disease. - Prevalence rose from 4% among adults ages 16 to 24 to 42% among people 75 and older. - That age gap suggests the market may benefit as older surgical populations grow. - The report’s regional outlook suggests market momentum is shifting beyond North America toward faster expansion in Asia-Pacific.

What's next: - The market’s next phase will likely depend on adoption of advanced sealants in minimally invasive and outpatient settings. - Further growth will also hinge on continued innovation in biomaterials and hemostatic products. - The report’s forecast implies sustained demand through the end of the decade as surgery volumes and cardiovascular cases rise. - The Business Research Company also said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspots infographics and updated graphics and tables.

The bottom line: - The vascular sealant market is moving from steady growth to sustained expansion, with surgery volume, cardiovascular disease and product innovation driving an expected 8% annual pace through 2030.